By Reuters |
January 25, 2019
Civica Rx initially expected to offer 14 drugs in 2019. It now believes it will exceed that number after forging relationships with several companies with licenses to manufacture additional medicines, company officials said in an interview.
Recent research on Paxlovid shows there is "solid data on its effectiveness," a co-author of the study told HealthLeaders.
A new personal protective equipment manufacturing company is set to open in Cincinnati next year.